Stockscreener 앱 받기
5.25
3.67%
-0.20
전일 마감가:
$5.45
열려 있는:
$5.48
하루 거래량:
2.15M
Relative Volume:
1.27
시가총액:
$284.50M
수익:
-
순이익/손실:
$-54.19M
주가수익비율:
-2.0349
EPS:
-2.58
순현금흐름:
$-37.34M
1주 성능:
+1.16%
1개월 성능:
+5.00%
6개월 성능:
-16.13%
1년 성능:
+0.19%
1일 변동 폭
$5.195
$5.685
1주일 범위
$4.9846
$5.685
52주 변동 폭
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
명칭
Abeona Therapeutics Inc
전화
646-813-4701
주소
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
ABEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.25 | 295.34M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-03-05 | 개시 | Oppenheimer | Outperform |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-30 | 개시 | Stifel | Buy |
| 2020-11-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-02-10 | 개시 | SVB Leerink | Outperform |
| 2019-12-10 | 재개 | Cantor Fitzgerald | Neutral |
| 2019-08-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2019-08-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2018-10-12 | 개시 | Mizuho | Buy |
| 2018-06-05 | 개시 | Seaport Global Securities | Buy |
| 2017-11-08 | 개시 | SunTrust | Buy |
| 2017-10-16 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-10-10 | 개시 | Citigroup | Buy |
| 2017-10-05 | 재확인 | Maxim Group | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-07-18 | 재확인 | Maxim Group | Buy |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2017-01-06 | 개시 | Jefferies | Buy |
| 2016-09-29 | 재확인 | Maxim Group | Buy |
모두보기
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
How (ABEO) Movements Inform Risk Allocation Models - Stock Traders Daily
Published on: 2026-01-17 07:33:28 - baoquankhu1.vn
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on Abeona Therapeutics stock By Investing.com - Investing.com Canada
Big Picture: Is Abeona Therapeutics Inc in a bullish channelQuarterly Earnings Report & Weekly Breakout Watchlists - baoquankhu1.vn
Is Abeona Therapeutics Inc. (PCJ) stock inflation resilient2025 Bull vs Bear & Daily Technical Stock Forecast Reports - Улправда
Why Abeona Therapeutics Inc. stock remains a top recommendationJuly 2025 Chart Watch & Proven Capital Preservation Methods - Улправда
How Abeona Therapeutics Inc. stock compares to industry benchmarksWeekly Trend Recap & Weekly High Potential Stock Alerts - Улправда
Will Abeona Therapeutics Inc. (PCJ) stock draw ESG focused funds2026 world cup usa national team round of 32 defensive leaders counter attacking knockout prediction guide - Улправда
Trading Systems Reacting to (ABEO) Volatility - Stock Traders Daily
3 Insider-Owned Growth Stocks For Your Watchlist - simplywall.st
Abeona Therapeutics announces employee inducement grants - MSN
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Abeona Therapeutics (ABEO) Issues Equity Awards to New Staff - GuruFocus
Abeona Therapeutics® announces new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New hires at Abeona Therapeutics get stock that vests over 3 years - Stock Titan
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Insider Sell: Vishwas Seshadri Sells 25,000 Shares of Abeona The - GuruFocus
Abeona Therapeutics (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 25,000 Shares - MarketBeat
Avoiding Lag: Real-Time Signals in (ABEO) Movement - Stock Traders Daily
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a Potential 281% Upside in Gene Therapy - DirectorsTalk Interviews
Is Abeona Therapeutics Inc. stock dividend yield sustainableEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - Улправда
Short Covering: Why institutional investors increase stakes in Abeona Therapeutics Inc. (PCJ) stockM&A Rumor & Weekly High Momentum Picks - Улправда
How Abeona Therapeutics Inc. stock performs in stagflation2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - Улправда
How Abeona Therapeutics Inc. stock performs in high volatility markets2025 Valuation Update & Precise Trade Entry Recommendations - Улправда
Can Abeona Therapeutics Inc. stock reach $100 price targetPortfolio Growth Summary & Low Risk High Win Rate Picks - ulpravda.ru
How Abeona Therapeutics Inc. stock reacts to global recession fearsTrade Entry Report & Real-Time Price Movement Reports - ulpravda.ru
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer By Investing.com - Investing.com Nigeria
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer - Investing.com
Abeona Therapeutics names Mohamad Tabrizi as chief business officer - marketscreener.com
Abeona Therapeutics Appoints Mohamad Tabrizi as Senior Vice President, Chief Business Officer - Quiver Quantitative
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - marketscreener.com
(ABEO) Risk Channels and Responsive Allocation - Stock Traders Daily
Quarterly Earnings: Will Abeona Therapeutics Inc stock benefit from M A activityJuly 2025 Sector Moves & Safe Capital Growth Tips - moha.gov.vn
AWM Investment Company Inc. Acquires New Shares in Abeona Therapeutics Inc. $ABEO - MarketBeat
Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Abeona Therapeutics (ABEO) Expands Zevaskyn Treatment Access in Texas - GuruFocus
Abeona Therapeutics Activates New Qualified Treatment Center for ZEVASKYN in Texas - Quiver Quantitative
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewswire
Is Abeona Therapeutics Inc a good long term investment - earlytimes.in
Abeona Therapeutics (ABEO) Begins First Commercial Use of ZEVASK - GuruFocus
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics Announces First Commercial Patient Treatment with FDA-Approved ZEVASKYN for Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics (Nasdaq: ABEO) begins commercial use of FDA-approved ZEVASKYN for RDEB - Stock Titan
Is Abeona Therapeutics Stock Built to Withstand a Pullback? - Trefis
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Abeona Therapeutics Inc. stock attractive to growth funds2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Will Abeona Therapeutics Inc. stock see PE expansionSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Abeona Therapeutics Inc (ABEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):